MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Mexico. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are EXPRESSION THERAPEUTICS LLC, PREC BIOSCIENCES INC and GILL PARKASH S.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Mexico | 1 | |
#4 | Singapore | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Izsvák Zsuzsanna | 3 |
#2 | Stein Ulrike | 2 |
#3 | Uckert Wolfgang | 2 |
#4 | Walther Wolfgang | 2 |
#5 | Wang Jichang | 2 |
#6 | Papavasileiou Panagiotis | 1 |
#7 | Felix Oden | 1 |
#8 | Gotthardt Michael | 1 |
#9 | Hurst Laurence Daniel | 1 |
#10 | Kaufmann Christopher | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020169812A1 | Pharmaceutical combination of wnt signaling and macc1 inhibitors | |
WO2017055487A2 | A METHOD FOR DIAGNOSING A DISEASE BY DETECTION OF circRNA IN BODILY FLUIDS | |
EP3204490A1 | Endogenous retrovirus transcription as a marker for primate naïve pluripotent stem cells | |
MX2016013767A | Humanized antibodies against cd269 (bcma). | |
EP2443255A2 | Csf1r-derived polynucleotides for medical use |